TFF Pharmaceuticals, Inc.
TFFP · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $193 | $650 | $203 | $734 |
| % Growth | -70.3% | 219.9% | -72.3% | – |
| Cost of Goods Sold | $0 | $141 | $140 | $131 |
| Gross Profit | $193 | $510 | $63 | $603 |
| % Margin | 100% | 78.4% | 31% | 82.2% |
| R&D Expenses | $1,695 | $2,588 | $3,556 | $2,974 |
| G&A Expenses | $2,081 | $2,024 | $2,320 | $2,509 |
| SG&A Expenses | $2,081 | $2,024 | $2,298 | $2,378 |
| Sales & Mktg Exp. | $0 | $0 | -$140 | -$131 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3,775 | $4,613 | $5,854 | $5,352 |
| Operating Income | -$3,582 | -$3,963 | -$5,994 | -$5,483 |
| % Margin | -1,852.3% | -609.4% | -2,948.8% | -747.1% |
| Other Income/Exp. Net | $37 | -$517 | $56 | $606 |
| Pre-Tax Income | -$3,545 | -$4,479 | -$5,735 | -$4,762 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3,545 | -$4,479 | -$5,735 | -$4,762 |
| % Margin | -1,833.1% | -688.9% | -2,821.4% | -648.9% |
| EPS | -0.81 | -1.22 | -2.4 | -2.01 |
| % Growth | 33.6% | 49.2% | -19.4% | – |
| EPS Diluted | -0.81 | -1.22 | -2.4 | -2.01 |
| Weighted Avg Shares Out | 4,372 | 3,667 | 2,388 | 2,366 |
| Weighted Avg Shares Out Dil | 4,372 | 3,667 | 2,388 | 2,366 |
| Supplemental Information | – | – | – | – |
| Interest Income | $37 | $44 | $56 | $106 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $141 | $140 | $131 |
| EBITDA | -$3,582 | -$3,822 | -$5,595 | -$5,238 |
| % Margin | -1,852.3% | -587.8% | -2,752.4% | -713.8% |